rs575909585
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_021098.3(CACNA1H):c.5512G>A(p.Val1838Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000509 in 1,552,426 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V1838V) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | NM_021098.3 | MANE Select | c.5512G>A | p.Val1838Ile | missense | Exon 33 of 35 | NP_066921.2 | ||
| CACNA1H | NM_001005407.2 | c.5494G>A | p.Val1832Ile | missense | Exon 32 of 34 | NP_001005407.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | TSL:1 MANE Select | c.5512G>A | p.Val1838Ile | missense | Exon 33 of 35 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | TSL:1 | c.5527G>A | p.Val1843Ile | missense | Exon 32 of 34 | ENSP00000454990.2 | ||
| CACNA1H | ENST00000711493.1 | c.5530G>A | p.Val1844Ile | missense | Exon 32 of 34 | ENSP00000518778.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152232Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000687 AC: 11AN: 160162 AF XY: 0.0000354 show subpopulations
GnomAD4 exome AF: 0.0000486 AC: 68AN: 1400076Hom.: 1 Cov.: 32 AF XY: 0.0000507 AC XY: 35AN XY: 690710 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152350Hom.: 0 Cov.: 34 AF XY: 0.0000671 AC XY: 5AN XY: 74500 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at